Zepto Tests Super Mall and Diagnostics Services to Expand Its Quick Commerce Portfolio

Zepto has started testing 2new offerings as part of its broader push to diversify beyond core grocery deliveries. As per the news reports, the pilots include Super Mall, a vertical focused on premium and higher-value categories, and Zepto Diagnostics, an in-app diagnostics service introduced under the pharmacy segment.  

Both initiatives are currently limited to select cities and user groups as the company measures demand, repeat usage and overall customer engagement before scaling them nationwide. 

Super Mall Expansion and Customer Incentives 

Through Super Mall, Zepto is exploring categories such as home décor, electronics and fashion in an effort to boost margins and attract new customers while retaining existing ones. The vertical also aligns with the company’s goal of increasing cart size, supported by targeted incentives like ₹50 off on orders above ₹1,099, ₹150 off on baskets over ₹2,299 and ₹200 off on orders exceeding ₹2,899.  

The model mirrors value-driven features seen in competing platforms, including Swiggy’s Maxxsaver, which unlocks lower prices for orders above ₹399. 

Strengthening the Pharma Segment Through Diagnostics 

Zepto Diagnostics forms part of the firm’s pharmacy category and has been launched in partnership with Orange Health Labs. The service enables users to book home blood tests with sample collection promised within 60 minutes and reports delivered in 6 hours.  

Available tests include full-body check-ups, complete blood count and thyroid function tests, among others. The pilot aims to help Zepto expand its presence in health-related services and evaluate how diagnostics can complement its existing offerings. 

Read More: ETERNAL (Formerly Zomato) Becomes India’s Fastest-Growing Major Brand in 2025! 

Conclusion 

Zepto’s pilot rollout of Super Mall and diagnostics services marks a strategic step toward widening its quick commerce portfolio. Insights from these trials will guide the company’s next phase of expansion as it considers broader integration of new verticals across its platform. 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.  

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.